Satsuma Pharmaceuticals (STSA) PT Lowered to $3.50 at Mizuho Securities
Tweet
Share
E-mailGet Alerts STSA Hot Sheet
Price: $1.10 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 8
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 8
Join SI Premium – FREE
Mizuho Securities analyst Vamil Divan lowered the price target on Satsuma Pharmaceuticals (NASDAQ: STSA) to $3.50 (from $4.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- salesforce.com (CRM) PT Raised to $222 at Monness, Crespi, Hardt
- Neurocrine Bio. (NBIX) PT Lowered to $182 at Morgan Stanley
- Kornit Digital Ltd. (KRNT) PT Raised to $19 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
